.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Express Scripts
Dow
Daiichi Sankyo
Chinese Patent Office
US Army
Teva
UBS
Cipla

Generated: December 15, 2017

DrugPatentWatch Database Preview

FEMTRACE Drug Profile

« Back to Dashboard

Which patents cover Femtrace, and what generic alternatives are available?

Femtrace is a drug marketed by Apil and is included in one NDA. There are three patents protecting this drug.

This drug has eleven patent family members in ten countries and twenty-seven supplementary protection certificates in eleven countries.

The generic ingredient in FEMTRACE is estradiol acetate. There are seventy-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estradiol acetate profile page.

Summary for FEMTRACE

Drug patent expirations by year for FEMTRACE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-001Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-003Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-002Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-003Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-001Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-001Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-002Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-002Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
ApilFEMTRACEestradiol acetateTABLET;ORAL021633-003Aug 20, 2004DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: FEMTRACE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)03055495► Subscribe
Norway20042565► Subscribe
Australia2002359758► Subscribe
MexicoPA04006057► Subscribe
Israel160797► Subscribe
China1564689► Subscribe
European Patent Office1461043► Subscribe
Japan2005517673► Subscribe
New Zealand532491► Subscribe
Canada2470703► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: FEMTRACE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2009004Lithuania► SubscribePRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
C/GB09/026United Kingdom► SubscribePRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208
156Luxembourg► SubscribePRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
2009 00017Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0002Belgium► SubscribePRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305
0136011/03Switzerland► SubscribePRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0018France► SubscribePRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Cantor Fitzgerald
Fish and Richardson
UBS
Cipla
Colorcon
Julphar
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot